No Data
No Data
Meikang Biotech (300439.SZ) received a medical device registration certificate
Meikang Biotech (300439.SZ) announced that the company recently obtained the “Medical...” issued by the Zhejiang Drug Administration
Meikang Biotech (300439.SZ): Net profit of 79.968 million yuan in the first quarter increased 10.76% year-on-year
Gelonghui, April 23 | Meikang Biotech (300439.SZ) released its report for the first quarter of 2024. Operating revenue for the reporting period was 482 million yuan, down 1.91% year on year; net profit attributable to shareholders of listed companies was 79.968 million yuan, up 10.76% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 64.749 million yuan, up 14.37% year on year; basic earnings per share were 0.21 yuan.
Meikang Biotech (300439.SZ): 2023 net profit of 257 million yuan, plans to distribute 10 to 1.34 yuan
Gelonghui, April 18 | Meikang Biotech (300439.SZ) announced its 2023 annual report. In 2023, the company achieved operating income of 1,886 billion yuan, a year-on-year decrease of 24.23%; net profit attributable to shareholders of listed companies was 255 million yuan, up 29.23% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 196 million yuan, up 14.89% year on year; basic income per share was 0.67 yuan; it plans to distribute a cash dividend of 1.34 yuan (tax included) to all shareholders for every 10 shares.
MedicalSystem Biotechnology Gets Nod to Market Fibrinogen Detection Kit
MedicalSystem Biotechnology (SHE:300439) received approval from the drug regulator of China's Zhejiang Province to market its fibrinogen detection kit, according to the company's filing published on t
Meikang Biology (300439.SZ): Suzhou Shengde passed the National High-tech Enterprise Certification
Gelonghui, March 21丨Meikang Biotech (300439.SZ) announced that Meikang Shengde Medical Technology (Suzhou) Co., Ltd. (“Suzhou Shengde”), a wholly-owned subsidiary of the company, recently received the “High-tech Enterprise Certificate” (certificate number: GR202332001909, date of issue: November 6, 2023, valid for three years).
Meikang Biotech (300439.SZ) obtained two medical device registration certificates
Meikang Biotech (300439.SZ) announced that the company obtained the “Medical Devices...” issued by the State Drug Administration
No Data